Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Revenue | $ | 150,659 | $ | 168,477 | $ | 558,775 | $ | 534,519 | ||||||||
Cost of operations | 52,979 | 51,859 | 201,677 | 187,831 | ||||||||||||
Sales and marketing | 30,165 | 34,085 | 124,326 | 120,874 | ||||||||||||
General and administrative | 23,657 | 23,146 | 91,271 | 85,496 | ||||||||||||
Depreciation and amortization | 6,872 | 7,310 | 26,801 | 27,578 | ||||||||||||
Interest income | 24 | 99 | 112 | 3,949 | ||||||||||||
Interest expense | 5,809 | 1,347 | 20,645 | 11,453 | ||||||||||||
Loss on convertible notes | — | 6,362 | — | 23,332 | ||||||||||||
Gain (loss) on investments | 3,837 | 13,460 | 18,516 | (9,517 | ) | |||||||||||
Transaction and other expense (income) | 2,275 | (20 | ) | 2,328 | 72 | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations before income tax provision | 32,763 | 57,947 | 110,355 | 72,315 | ||||||||||||
Income tax provision | 13,561 | 24,183 | 46,167 | 20,043 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations | 19,202 | 33,764 | 64,188 | 52,272 | ||||||||||||
Income from discontinued operations, net of tax | — | 2,824 | 10,388 | 1,800 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 19,202 | $ | 36,588 | $ | 74,576 | $ | 54,072 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Basic income per common share: | ||||||||||||||||
Income from continuing operations | $ | 0.34 | $ | 0.58 | $ | 1.11 | $ | 0.93 | ||||||||
Income from discontinued operations | — | 0.05 | 0.18 | 0.04 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 0.34 | $ | 0.63 | $ | 1.29 | $ | 0.97 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted income per common share: | ||||||||||||||||
Income from continuing operations | $ | 0.33 | $ | 0.55 | $ | 1.08 | $ | 0.85 | ||||||||
Income from discontinued operations | — | 0.04 | 0.17 | 0.03 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 0.33 | $ | 0.59 | $ | 1.25 | $ | 0.88 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Weighted-average shares outstanding used in computing income per common share: | ||||||||||||||||
Basic | 55,685 | 57,505 | 57,356 | 55,328 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | 68,326 | 62,330 | 59,124 | 62,228 | ||||||||||||
|
|
|
|
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Revenue | ||||||||||||||||
Public portal advertising and sponsorship | $ | 130,821 | $ | 147,042 | $ | 477,325 | $ | 446,969 | ||||||||
Private portal services | 19,838 | 21,435 | 81,450 | 87,550 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 150,659 | $ | 168,477 | $ | 558,775 | $ | 534,519 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a) | $ | 54,626 | $ | 69,082 | $ | 181,238 | $ | 173,618 | ||||||||
Interest, taxes, non-cash and other items (b) | ||||||||||||||||
Interest income | 24 | 99 | 112 | 3,949 | ||||||||||||
Interest expense | (5,809 | ) | (1,347 | ) | (20,645 | ) | (11,453 | ) | ||||||||
Income tax provision | (13,561 | ) | (24,183 | ) | (46,167 | ) | (20,043 | ) | ||||||||
Depreciation and amortization | (6,872 | ) | (7,310 | ) | (26,801 | ) | (27,578 | ) | ||||||||
Non-cash stock-based compensation | (10,768 | ) | (9,695 | ) | (39,737 | ) | (33,300 | ) | ||||||||
Loss on convertible notes | — | (6,362 | ) | — | (23,332 | ) | ||||||||||
Gain (loss) on investments | 3,837 | 13,460 | 18,516 | (9,517 | ) | |||||||||||
Transaction and other (expense) income | (2,275 | ) | 20 | (2,328 | ) | (72 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations | 19,202 | 33,764 | 64,188 | 52,272 | ||||||||||||
Income from discontinued operations, net of tax | — | 2,824 | 10,388 | 1,800 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 19,202 | $ | 36,588 | $ | 74,576 | $ | 54,072 | ||||||||
|
|
|
|
|
|
|
|
(a) See Annex A-Explanation of Non-GAAP Financial Measures.
(b) Reconciliation of Adjusted EBITDA to net income.
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
December 31, | ||||||||
2011 | 2010 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 1,121,217 | $ | 400,501 | ||||
Accounts receivable, net | 121,335 | 134,448 | ||||||
Prepaid expenses and other current assets | 12,690 | 12,161 | ||||||
Deferred tax assets | 20,482 | 23,467 | ||||||
|
|
|
| |||||
Total current assets | 1,275,724 | 570,577 | ||||||
Property and equipment, net | 57,139 | 61,516 | ||||||
Goodwill | 202,104 | 202,104 | ||||||
Intangible assets, net | 19,999 | 22,626 | ||||||
Deferred tax assets | 55,017 | 71,125 | ||||||
Other assets | 31,042 | 14,254 | ||||||
|
|
|
| |||||
Total Assets | $ | 1,641,025 | $ | 942,202 | ||||
|
|
|
| |||||
Liabilities and Stockholders’ Equity | ||||||||
Accrued expenses | $ | 55,238 | $ | 53,181 | ||||
Deferred revenue | 88,055 | 97,043 | ||||||
Liabilities of discontinued operations | 1,506 | 17,327 | ||||||
|
|
|
| |||||
Total current liabilities | 144,799 | 167,551 | ||||||
2.25% convertible notes due 2016 | 400,000 | — | ||||||
2.50% convertible notes due 2018 | 400,000 | — | ||||||
Other long-term liabilities | 21,790 | 21,756 | ||||||
Stockholders’ equity | 674,436 | 752,895 | ||||||
|
|
|
| |||||
Total Liabilities and Stockholders’ Equity | $ | 1,641,025 | $ | 942,202 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Years Ended December 31, | ||||||||
2011 | 2010 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 74,576 | $ | 54,072 | ||||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ||||||||
Income from discontinued operations, net of tax | (10,388 | ) | (1,800 | ) | ||||
Depreciation and amortization | 26,801 | 27,578 | ||||||
Non-cash interest, net | 3,758 | 5,594 | ||||||
Non-cash stock-based compensation | 39,737 | 33,300 | ||||||
Deferred income taxes | 13,696 | (403 | ) | |||||
Loss on convertible notes | — | 23,332 | ||||||
(Gain) loss on investments | (18,516 | ) | 9,517 | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 13,113 | (16,292 | ) | |||||
Prepaid expenses and other, net | 1,416 | 4,617 | ||||||
Accrued expenses and other long-term liabilities | 2,511 | 213 | ||||||
Deferred revenue | (8,988 | ) | (1,431 | ) | ||||
|
|
|
| |||||
Net cash provided by continuing operations | 137,716 | 138,297 | ||||||
Net cash used in discontinued operations | (440 | ) | (16,474 | ) | ||||
|
|
|
| |||||
Net cash provided by operating activities | 137,276 | 121,823 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds from sales of available-for-sale securities | — | 361,852 | ||||||
Proceeds received from ARS option | 21,566 | 10,467 | ||||||
Purchases of property and equipment | (20,911 | ) | (32,254 | ) | ||||
Finalization of sale price of discontinued operations | — | (1,430 | ) | |||||
|
|
|
| |||||
Net cash provided by investing activities | 655 | 338,635 | ||||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 28,339 | 59,825 | ||||||
Cash used for withholding taxes due on stock-based awards | (9,234 | ) | (86,533 | ) | ||||
Net proceeds from issuance of the 2.50% Notes and 2.25% Notes | 774,745 | — | ||||||
Repurchases of 1.75% Notes and 3 1/8% Notes | — | (94,525 | ) | |||||
Purchases of treasury stock | (241,263 | ) | (420,948 | ) | ||||
Excess tax benefit on stock-based awards | 30,198 | 22,458 | ||||||
|
|
|
| |||||
Net cash provided by (used in) financing activities | 582,785 | (519,723 | ) | |||||
|
|
|
| |||||
Net increase (decrease) in cash and cash equivalents | 720,716 | (59,265 | ) | |||||
Cash and cash equivalents at beginning of period | 400,501 | 459,766 | ||||||
|
|
|
| |||||
Cash and cash equivalents at end of period | $ | 1,121,217 | $ | 400,501 | ||||
|
|
|
|
WEBMD HEALTH CORP.
NET INCOME PER COMMON SHARE
(In thousands, except per share data, unaudited)
Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Numerator: | ||||||||||||||||
Income from continuing operations | $ | 19,202 | $ | 33,764 | $ | 64,188 | $ | 52,272 | ||||||||
Effect of participating non-vested restricted stock | (111 | ) | (339 | ) | (436 | ) | (601 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations-Basic | 19,091 | 33,425 | 63,752 | 51,671 | ||||||||||||
Interest expense on 2.50% Notes, net of tax | 1,682 | — | — | — | ||||||||||||
Interest expense on 2.25% Notes, net of tax | 1,627 | — | — | — | ||||||||||||
Interest expense on 1.75% Notes, net of tax | — | — | — | 1,469 | ||||||||||||
Interest expense on 3 1/8% Notes, net of tax | — | 809 | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income from continuing operations — Diluted | $ | 22,400 | $ | 34,234 | $ | 63,752 | $ | 53,140 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Income from discontinued operations, net of tax | $ | — | $ | 2,824 | $ | 10,388 | $ | 1,800 | ||||||||
Effect of participating non-vested restricted stock | — | (28 | ) | (71 | ) | (21 | ) | |||||||||
|
|
|
|
|
|
|
| |||||||||
Income from discontinued operations, net of tax — Basic and Diluted | $ | — | $ | 2,796 | $ | 10,317 | $ | 1,779 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Denominator: | ||||||||||||||||
Weighted-average shares-Basic | 55,685 | 57,505 | 57,356 | 55,328 | ||||||||||||
Employee stock options and restricted stock | 1,164 | 2,651 | 1,768 | 3,706 | ||||||||||||
2.50% Notes | 6,049 | — | — | — | ||||||||||||
2.25% Notes | 5,428 | — | — | — | ||||||||||||
1.75% Notes | — | — | — | 3,194 | ||||||||||||
3 1/8% Notes | — | 2,174 | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Adjusted weighted-average shares after assumed conversions — Diluted | 68,326 | 62,330 | 59,124 | 62,228 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Basic income per common share: | ||||||||||||||||
Income from continuing operations | $ | 0.34 | $ | 0.58 | $ | 1.11 | $ | 0.93 | ||||||||
Income from discontinued operations | — | 0.05 | 0.18 | 0.04 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 0.34 | $ | 0.63 | $ | 1.29 | $ | 0.97 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted income per common share: | ||||||||||||||||
Income from continuing operations | $ | 0.33 | $ | 0.55 | $ | 1.08 | $ | 0.85 | ||||||||
Income from discontinued operations | — | 0.04 | 0.17 | 0.03 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income | $ | 0.33 | $ | 0.59 | $ | 1.25 | $ | 0.88 | ||||||||
|
|
|
|
|
|
|
|